Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample

Molecular Psychiatry

Volumn 19, Issue 5, 2014, Pages 615-624

  Loukola, A ^a   Wedenoja, J ^a   Keskitalo Vuokko, K ^a   Broms, U ^a,b   Korhonen, T ^a,b   Ripatti, S ^a,b,c   Sarin, A P ^a,b   Pitkaniemi J ^a   He, L ^a   Happola A ^a   Heikkila K ^a   Chou, Y L ^d   Pergadia, M L ^d   Heath, A C ^d   Montgomery, G W ^e   Martin, N G ^e   Madden, P A F ^d   Kaprio, J ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

ADHD; genome wide association analysis; nicotine dependence; schizophrenia; smoking behavior; smoking quantity

Indexed keywords

ALPHA TROPOMYOSIN; BETA LACTAMASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; NEUREGULIN 3; NICOTINE; UNCLASSIFIED DRUG; ERBB4 PROTEIN, HUMAN; MANNOSYL(ALPHA 1,6 )GLYCOPROTEIN BETA 1,6 N ACETYL GLUCOSAMINYL TRANSFERASE; NCK ASSOCIATED PROTEIN 5; NEU DIFFERENTIATION FACTOR 3; PROTEIN;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITION; COHORT ANALYSIS; DNA FLANKING REGION; DSM-IV; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LOAD; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TWINS; WECHSLER INTELLIGENCE SCALE; WECHSLER MEMORY SCALE; DIZYGOTIC TWINS; DRUG SEEKING BEHAVIOR; FAMILY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MONOZYGOTIC TWINS; PSYCHOLOGY; ANIMAL EXPERIMENT; AUSTRALIAN; CLINICAL TRIAL (TOPIC); FINN (CITIZEN); GENE CLUSTER; GENETIC CODE; GENETIC LINKAGE; MOUSE; NONHUMAN; WITHDRAWAL SYNDROME;

COHORT STUDIES; DRUG-SEEKING BEHAVIOR; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; RECEPTOR, ERBB-4; SMOKING; TOBACCO USE DISORDER; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84899481501     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.72     Document Type: Article

References (91)

1. Centers for Disease Control (CDC). Smoking-attributable mortality, years ofpotential life lost, and productivity losses-United States, 2000-2004. MMWRMorb Mortal Wkly Rep 2008; 57: 1226-1228.
2. Steuber TL, Danner F. Adolescent smoking and depression: which comes first?Addict Behav 2006; 31: 133-136. (Pubitemid 41790455)
3. Munafò MR, Hitsman B, Rende R, Metcalfe C, Niaura R. Effects of progression tocigarette smoking on depressed mood in adolescents: evidence from the NationalLongitudinal Study of Adolescent Health. Addiction 2008; 103: 162-171. (Pubitemid 350233418)
4. Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: testsof causal linkage using a longitudinal birth cohort. Br J Psychiatry 2010; 196:440-446.
5. Munafò MR, Araya R. Cigarette smoking and depression: a question of causation.Br J Psychiatry 2010; 196: 425-426.
6. Benowitz NL. Nicotine addiction. N Engl J Med 2010; 362: 2295-2303.
7. American Psychiatric Association. Diagnostic and Statistical Manual of MentalDisorders: DSM-IV. 4th edn. (American Psychiatric Association: Washington DC,USA, 1994.
8. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The FagerströmTest for Nicotine Dependence: a revision of the Fagerström ToleranceQuestionnaire. Br J Addict 1991; 86: 1119-1127.
9. Rose JE, Broms U, Korhonen T, Dick DM, Kaprio J. Genetics of smoking behavior.In: Kim YK (ed). Handbook of Behavior Genetics. Springer: New York, NY, USA,pp 411-432, 2009.
10. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D et al.A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptorsubunit genes on 15q25. Nature 2008; 452: 633-637. (Pubitemid 351483367)
11. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T et al. Genome-wide associationscan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.Nat Genet 2008; 40: 616-622. (Pubitemid 351601203)
12. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al. A variantassociated with nicotine dependence, lung cancer and peripheral arterial disease.Nature 2008; 452: 638-642. (Pubitemid 351483366)
13. Keskitalo K, Broms U, Heliö vaara M, Ripatti S, Surakka I, Perola M et al. Associationof serum cotinine level with a cluster of three nicotinic acetylcholine receptorgenes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 2009; 18:4007-4012.
14. Munafò MR, Timofeeva MN, Morris RW, Prieto-Merino D, Sattar N, Brennan P et al.Association between genetic variants on chromosome 15q25 locus and objectivemeasures of tobacco exposure. J Natl Cancer Inst 2012; 104: 740-748.
15. Shiffman S, Waters A, Hickcox M. The Nicotine Dependence Syndrome Scale: amultidimensional measure of nicotine dependence. Nicotine Tob Res 2004; 6:327-348. (Pubitemid 38678863)
16. Broms U, Wedenoja J, Largeau MR, Korhonen T, Pitkäniemi J, Keskitalo-Vuokko Ket al. Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4gene cluster association with several nicotine dependence traits. Nicotine Tob Res2012; 14: 720-733.
17. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE. Molecular genetics ofnicotine dependence and abstinence: whole genome association using 520,000SNPs. BMC Genet 2007; 8: 10.
18. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF et al.Novel genes identified in a high-density genome wide association study fornicotine dependence. Hum Mol Genet 2007; 16: 24-35. (Pubitemid 46152542)
19. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L et al. Meta-analysisand imputation refines the association of 15q25 with smoking quantity. Nat Genet2010; 42: 436-440.
20. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multipleloci associated with smoking behavior. Nat Genet 2010; 42: 441-447.
21. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al.Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. NatGenet 2010; 42: 448-453.
22. Vink JM, Smit AB, de Geus EJ, Sullivan P, Willemsen G, Hottenga JJ et al. Genomewideassociation study of smoking initiation and current smoking. Am J HumGenet 2009; 84: 367-379.
23. Liu YZ, Pei YF, Guo YF, Wang L, Liu XG, Yan H et al. Genome-wide associationanalyses suggested a novel mechanism for smoking behavior regulated by IL15.Mol Psychiatry 2009; 14: 668-680.
24. Lind PA, Macgregor S, Vink JM, Pergadia ML, Hansell NK, de Moor MH et al. Agenomewide association study of nicotine and alcohol dependence in Australianand Dutch populations. Twin Res Hum Genet 2010; 13: 10-29.
25. Yoon D, Kim YJ, Cui WY, Van der Vaart A, Cho YS, Lee JY et al. Large-scale genomewideassociation study of Asian population reveals genetic factors in FRMD4A andother loci influencing smoking initiation and nicotine dependence. Hum Genet2011; 131: 1009-1021.
26. Drgon T, Montoya I, Johnson C, Liu QR, Walther D, Hamer D et al. Genome-wideassociation for nicotine dependence and smoking cessation success in NIHresearch volunteers. Mol Med 2009; 15: 21-27.
27. Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, Yeager M et al. Genome-wideand candidate gene association study of cigarette smoking behaviors.PLoS ONE 2009; 4: e4653.
28. Siedlinski M, Cho MH, Bakke P, Gulsvik A, Lomas DA, Anderson W et al. Genomewideassociation study of smoking behaviors in patients with COPD. Thorax 2011;66: 894-902.
29. Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DS, Chen X,Cichon S et al. Multiple independent loci at chromosome 15q25.1 affect smokingquantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet2010; 6: e1001053.
30. Broms U, Madden PA, Heath AC, Pergadia ML, Shiffman S, Kaprio J. The NicotineDependence Syndrome Scale in Finnish smokers. Drug Alcohol Depend 2007; 89:42-51. (Pubitemid 46602871)
31. Loukola A, Broms U, Maunu H, Widén E, Heikkilä K, Siivola M et al. Linkage ofnicotine dependence and smoking behavior on 10q, 7q and 11p in twins withhomogeneous genetic background. Pharmacogenomics J 2008; 8: 209-219. (Pubitemid 351712645)
32. Saccone SF, Pergadia ML, Loukola A, Broms U, Montgomery GW, Wang JC et al.Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait intwo independent samples. Am J Hum Genet 2007; 80: 856-866. (Pubitemid 46668454)
33. Hartz SM, Short SE, Saccone NL, Culverhouse R, Chen L, Schwantes-An TH et al.Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers.Arch Gen Psychiatry 2012; 69: 854-860.
34. Knaapila A, Silventoinen K, Broms U, Rose RJ, Perola M, Kaprio J et al. Foodneophobia in young adults: genetic architecture and relation to personality,pleasantness and use frequency of foods, and body mass index-a twin study.Behav Genet 2011; 41: 512-521.
35. Heath AC, Whitfield JB, Martin NG, Pergadia ML, Goate AM, Lind PA et al. Aquantitative-trait genome-wide association study of alcoholism risk in the community:findings and implications. Biol Psychiatry 2011; 70: 513-518.
36. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, NurnbergerJr JI et al. A new, semi-structured psychiatric interview for use in genetic linkagestudies: a report on the reliability of the SSAGA. J Stud Alcohol 1994; 55: 149-158. (Pubitemid 24080088)
37. Cottler LB, Robins LN, Grant BF, Blaine J, Towle LH, Wittchen HU et al. The CIDIcoresubstance abuse and dependence questions: cross-cultural and nosologicalissues. The WHO/ADAMHA Field Trial. Br J Psychiatry 1991; 159: 653-658.
38. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphismsin linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-769. (Pubitemid 38420107)
39. Raine A, Benishay D. The SPQ-B: a brief screening instrument for schizotypalpersonality disorder. J Pers Disord 1995; 9: 346-355. (Pubitemid 26014344)
40. Raine A, Reynolds C, Lencz T, Scerbo A, Triphon N, Kim D. Cognitive-perceptualinterpersonal, and disorganized features of schizotypal personality. Schizophr Bull1994; 20: 191-201. (Pubitemid 24071102)
41. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputationmethod for the next generation of genome-wide association studies. PLoS Genet2009; 5: e1000529.
42. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: atool set for whole-genome association and population-based linkage analyses.Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
43. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD andhaplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
44. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatilegene-based test for genome-wide association studies. Am J Hum Genet 2010; 87:139-145.
45. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X et al. Variants innicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008; 165:1163-1171.
46. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular a5 nicotinicreceptor subunit signalling controls nicotine intake. Nature 2011; 471: 597-601.
47. Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse andmental illness. Nat Neurosci 2005; 8: 1465-1470. (Pubitemid 41573657)
48. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewideassociation scans. Genet Epidemiol 2008; 32: 227-234. (Pubitemid 351550369)
49. Pe'er I, Yelensky R, Altshuler D, Daly MJ. Estimation of the multiple testing burdenfor genomewide association studies of nearly all common variants. Genet Epidemiol2008; 32: 381-385. (Pubitemid 351656309)
50. Sullivan P. on behalf of 96 psychiatric genetics investigators. Don't give up onGWAS. Mol Psychiatry 2012; 17: 2-3.
51. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am JHum Genet 2012; 90: 7-24.
52. Browning SR, Browning BL. Haplotype phasing: existing methods and newdevelopments. Nat Rev Genet 2011; 12: 703-714.
53. Moss HB, Chen CM, Yi HY. Measures of substance consumption among substanceusers, DSM-IV abusers, and those with DSM-IV dependence disorders in anationally representative sample. J Stud Alcohol Drugs 2012; 73: 820-828.
54. Kaprio J, Koskenvuo M. Genetic and environmental factors in complex diseases:the older Finnish Twin Cohort. Twin Res 2002; 5: 358-365. (Pubitemid 35315484)
55. Han S, Gelernter J, Luo X, Yang BZ. Meta-analysis of 15 genome-wide linkagescans of smoking behavior. Biol Psychiatry 2010; 67: 12-19.
56. Romanos M, Freitag C, Jacob C, Craig DW, Dempfle A, Nguyen TT et al. Genomewidelinkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1and 14q12. Mol Psychiatry 2008; 13: 522-530. (Pubitemid 351556035)
57. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C et al. A genomewidescan for attention-deficit/hyperactivity disorder in an extended sample:suggestive linkage on 17p11. Am J Hum Genet 2003; 72: 1268-1279. (Pubitemid 36530013)
58. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL et al. Agenomewide scan for loci involved in attention-deficit/hyperactivity disorder. AmJ Hum Genet 2002; 70: 1183-1196. (Pubitemid 34450569)
59. Lerman C, Audrain J, Tercyak K, Hawk Jr LW, Bush A, Crystal-Mansour S et al.Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patternsamong participants in a smoking-cessation program. Nicotine Tob Res 2001; 3:353-359. (Pubitemid 33101062)
60. Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF.Smoking patterns and abstinence effects in smokers with no ADHD, childhoodADHD, and adult ADHD symptomatology. Addict Behav 2003; 28: 1149-1157. (Pubitemid 36808522)
61. Sihvola E, Rose RJ, Dick DM, Korhonen T, Pulkkinen L, Raevuori A et al. Prospectiverelationships of ADHD symptoms with developing substance use in a populationderivedsample. Psychol Med 2011; 20: 1-9.
62. Shi SH, Jan LY, Jan YN. Hippocampal neuronal polarity specified by spatiallylocalized mPar3/mPar6 and PI 3-kinase activity. Cell 2003; 112: 63-75. (Pubitemid 36106419)
63. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE et al. Molecular genetics ofsuccessful smoking cessation: convergent genome-wide association study results.Arch Gen Psychiatry 2008; 65: 683-693. (Pubitemid 351787239)
64. Burden S, Yarden Y. Neuregulins and their receptors: a versatile signaling modulein organogenesis and oncogenesis. Neuron 1997; 18: 847-855. (Pubitemid 27274603)
65. Moolchan ET, Radzius A, Epstein DH, Uhl G, Gorelick DA, Cadet JL et al. TheFagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule:do they diagnose the same smokers? Addict Behav 2002; 27: 101-113. (Pubitemid 34031734)
66. Piper ME, McCarthy DE, Baker TB. Assessing tobacco dependence: a guide tomeasure evaluation and selection. Nicotine Tob Res 2006; 8: 339-351. (Pubitemid 43977036)
67. Bevilacqua L, Doly S, Kaprio J, Yuan Q, Tikkanen R, Paunio T et al. A population-specificHTR2B stop codon predisposes to severe impulsivity. Nature 2010; 468: 1061-1066.
68. Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM et al.Evidence that interaction between neuregulin 1 and its receptor erbB4 increasessusceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006;141B: 96-101. (Pubitemid 43062550)
69. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. The involvement of ErbB4with schizophrenia: association and expression studies. Am J Med Genet B NeuropsychiatrGenet 2006; 141B: 142-148. (Pubitemid 43214789)
70. Nicodemus KK, Luna A, Vakkalanka R, Goldberg T, Egan M, Straub RE et al. Furtherevidence for association between ErbB4 and schizophrenia and influence oncognitive intermediate phenotypes in healthy controls. Mol Psychiatry 2006; 11:1062-1065. (Pubitemid 44863428)
71. Law AJ, Kleinman JE, Weinberger DR, Weickert CS. Disease-associated intronicvariants in the ErbB4 gene are related to altered ErbB4 splice-variant expression inthe brain in schizophrenia. Hum Mol Genet 2007; 16: 129-141. (Pubitemid 46178996)
72. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T et al. Metaanalysisof 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2009;14: 774-785.
73. Golub MS, Germann SL, Lloyd KC. Behavioral characteristics of a nervous systemspecificerbB4 knock-out mouse. Behav Brain Res 2004; 153: 159-170. (Pubitemid 38829299)
74. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH et al. Alteredneuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction inschizophrenia. Nat Med 2006; 12: 824-828. (Pubitemid 44050073)
75. Zuliani R, Moorhead TW, Bastin ME, Johnstone EC, Lawrie SM, Brambilla P et al.Genetic variants in the ErbB4 gene are associated with white matter integrity.Psychiatry Res 2011; 191: 133-137.
76. Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA et al. Genome-wide scanin a nationwide study sample of schizophrenia families in Finland reveals susceptibilityloci on chromosomes 2q and 5q. Hum Mol Genet 2001; 10: 3037-3048. (Pubitemid 34083490)
77. Paunio T, Tuulio-Henriksson A, Hiekkalinna T, Perola M, Varilo T, Partonen T et al.Search for cognitive trait components of schizophrenia reveals a locus for verballearning and memory on 4q and for visual working memory on 2q. Hum MolGenet 2004; 13: 1693-1702. (Pubitemid 39173439)
78. Service S, DeYoung J, Karayiorgou M, Roos JL, Pretorious H, Bedoya G et al.Magnitude and distribution of linkage disequilibrium in population isolates andimplications for genome-wide association studies. Nat Genet 2006; 38: 556-560.
79. Peltonen L, Palotie A, Lange K. Use of population isolates for mapping complextraits. Nat Rev Genet 2000; 1: 182-190.
80. Surakka I, Kristiansson K, Anttila V, Inouye M, Barnes C, Moutsianas L et al. Founderpopulation-specific HapMap panel increases power in GWA studiesthrough improved imputation accuracy and CNV tagging. Genome Res 2010; 20:1344-1351.
81. Johnson C, Drgon T, Liu QR, Zhang PW, Walther D, Li CY et al. Genome wideassociation for substance dependence: convergent results from epidemiologicand research volunteer samples. BMC Med Genet 2008; 9: 113-122.
82. Drgon T, Johnson CA, Nino M, Drgonova J, Walther DM, Uhl GR. "Replicated"genome wide association for dependence on illegal substances: genomic regionsidentified by overlapping clusters of nominally positive SNPs. Am J Med Genet BNeuropsychiatr Genet 2011; 156: 125-138.
83. Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T et al. Genome-wideassociation for methamphetamine dependence: convergent results from 2 samples.Arch Gen Psychiatry 2008; 65: 345-355.
84. Uhl GR, Drgon T, Johnson C, Walther D, David SP, Aveyard P et al. Genome-wideassociation for smoking cessation success: participants in the Patch in Practicetrial of nicotine replacement. Pharmacogenomics 2010; 11: 357-367.
85. Wang KS, Liu X, Zhang Q, Pan Y, Aragam N, Zeng M. A meta-analysis of twogenome-wide association studies identifies 3 new loci for alcohol dependence.J Psychiatr Res 2011; 45: 1419-1425.
86. Wang KS, Liu X, Zhang Q, Wu LY, Zeng M. Genome-wide association studyidentifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawalsymptoms. J Neural Transm 2012; 199: 425-433.
87. Kendler KS, Kalsi G, Holmans PA, Sanders AR, Aggen SH, Dick DM et al. Genomewideassociation analysis of symptoms of alcohol dependence in the moleculargenetics of schizophrenia (MGS2) control sample. Alcohol Clin Exp Res 2011; 35:963-975.
88. Uhl GR, Drgon T, Johnson C, Ramoni MF, Behm FM, Rose JE. Genome-wideassociation for smoking cessation success in a trial of precessation nicotinereplacement. Mol Med 2010; 16: 513-526.
89. Zuo L, Gelernter J, Zhang CK, Zhao H, Lu L, Kranzler HR et al. Genome-wideassociation study of alcohol dependence implicates KIAA0040 on chromosome1q. Neuropsychopharmacology 2012; 37: 557-566.
90. Drgon T, Zhang PW, Johnson C, Walther D, Hess J, Nino M et al. Genome wideassociation for addiction: replicated results and comparisons of two analyticapproaches. PLoS One 2010; 5: e8832.
91. Young P, Nie J, Wang X, McGlade CJ, Rich MM, Feng G. LNX1 is a perisynapticSchwann cell specific E3 ubiquitin ligase that interacts with ErbB2. Mol CellNeurosci 2005; 30: 238-248. (Pubitemid 41316566)